EPHE
iShares MSCI Philippines ETF
EPHE tracks a market-cap-weighted index of the broader Filipino equity market.
Emerging Market
EQUITY
Rules-Based
MANAGEMENT STYLE
$ 131.8 M
ASSETS UNDER MGMT
59 bp
EXPENSES
Fund Basics
| Inception date | Sep 28, 2010 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | Semi-annual |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | Yes |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
Constituent Breakdown
| Number of holdings | 35 |
| Herfindahl-Hirschman Index | 805 |
| Wgt avg mkt cap (mns) | $8,510 |
| Large cap (>$10bn) | 47.4% |
| Mid cap ($2-10bn) | 32.5% |
| Small cap (<$2bn) | 11.2% |
| Developed mkts. | 88.0% |
| Emerging mkts. | 0.0% |
Sector Breakdown
Country Exposure
Historical Performance
Standardized Performance (as of 04/30/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | -2.9% | -10.0% | -3.1% | -3.6% | -3.5% | -3.6% | -- | -0.2% |
| Dividend Yield | 0.0% | 1.8% | 2.1% | 2.1% | 1.8% | 1.2% | -- | 1.1% |
| Total Returns | -2.9% | -8.2% | -1.0% | -1.5% | -1.7% | -2.5% | -- | 0.9% | Ann. Volatility | 20.6% | 18.9% | 18.8% | 17.5% | 18.1% | 22.3% | -- | 22.2% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.51 | 11% |
| MSCI EAFE | 0.56 | 19% |
| MSCI Emg Mkts | 0.45 | 19% |
Liquidity Measures
| Avg. volume (000) | 85 |
| ADV traded (mns) | $2 |
| Turnover | 1.6% |
| Avg. Bid/Ask (% of price) | 0.28% |
Technical Indicators
| 30d moving avg. (EMA) | $24.89 |
| Relative strength (RSI) | 46 |
| MACD/Signal | -0.08/-0.11 |
| Bollinger Bands (Upper/Lower) | $25.48/$23.97 |
| Short interest (% of AUM) | 7.3% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. EPHE |
Expenses vs. EPHE |
ALTAR Score™ vs. EPHE |
|---|
Risk and Returns: EPHE vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 5/18/2026
Peer Group Comparison
Sample data. Subscribe for access.
Historical Valuation Trends Sample data. Subscribe for access.
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
0.0%
ALTAR SCORE™
PERCENTILE
AVOID
ETFRC RATING
There are 200 funds in the Emerging Equity category with an average
ALTAR Score™ of 7.6% and a standard deviation
of 2.2%. EPHE's ALTAR Score™ is approximately 0.0 standard
deviations above the category average. This places EPHE in the percentile
among funds in the category.
Sell-Side Consensus
$31.35
PRICE TARGET
+27.2%
UPSIDE